- Home
- USIO vs JSPR Comparison
USIO vs JSPR Comparison
Compare USIO & JSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USIO
- JSPR
- Stock Information
- Founded
- USIO 1998
- JSPR 2018
- Country
- USIO United States
- JSPR United States
- Employees
- USIO N/A
- JSPR N/A
- Industry
- USIO Investment Bankers/Brokers/Service
- JSPR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- USIO Finance
- JSPR Health Care
- Exchange
- USIO Nasdaq
- JSPR Nasdaq
- Market Cap
- USIO 50.2M
- JSPR 46.7M
- IPO Year
- USIO N/A
- JSPR N/A
- Fundamental
- Price
- USIO $1.52
- JSPR $3.11
- Analyst Decision
- USIO Strong Buy
- JSPR Buy
- Analyst Count
- USIO 1
- JSPR 12
- Target Price
- USIO $4.00
- JSPR $30.78
- AVG Volume (30 Days)
- USIO 104.3K
- JSPR 311.4K
- Earning Date
- USIO 08-06-2025
- JSPR 08-13-2025
- Dividend Yield
- USIO N/A
- JSPR N/A
- EPS Growth
- USIO N/A
- JSPR N/A
- EPS
- USIO 0.11
- JSPR N/A
- Revenue
- USIO $83,851,606.00
- JSPR N/A
- Revenue This Year
- USIO $16.02
- JSPR N/A
- Revenue Next Year
- USIO $13.24
- JSPR N/A
- P/E Ratio
- USIO $14.21
- JSPR N/A
- Revenue Growth
- USIO 2.05
- JSPR N/A
- 52 Week Low
- USIO $1.24
- JSPR $2.27
- 52 Week High
- USIO $2.92
- JSPR $26.05
- Technical
- Relative Strength Index (RSI)
- USIO 42.47
- JSPR 45.86
- Support Level
- USIO $1.38
- JSPR $2.81
- Resistance Level
- USIO $2.02
- JSPR $3.04
- Average True Range (ATR)
- USIO 0.13
- JSPR 0.21
- MACD
- USIO -0.03
- JSPR 0.10
- Stochastic Oscillator
- USIO 21.87
- JSPR 94.29
About USIO Usio Inc.
Usio Inc is a United States-based company that provides integrated electronic payment services, including credit and debit card-based processing services and transaction processing via the Automated Clearing House, or ACH network to billers and retailers. The Company also has an additional wholly-owned subsidiary, which is the entity for Output Solutions operations.
About JSPR Jasper Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.